InvestorsHub Logo
Post# of 252342
Next 10
Followers 833
Posts 119913
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 131630

Tuesday, 11/29/2011 9:37:19 PM

Tuesday, November 29, 2011 9:37:19 PM

Post# of 252342
Blair analyst, Katherine Xu says PSI-7977 plus VRUS’ “other” HCV drugs will attain peak annual sales of $14B (!):

http://finance.yahoo.com/news/Sector-Snap-Hepatitis-C-apf-499222132.html?x=0

Not helping Xu’s credibility is the fact that she lowered the price target on VRTX from $57 to $45. (The stock is currently trading at $27 and change.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.